Previous Article | Next Article ![]()
Infection and Immunity, April 2001, p. 2589-2595, Vol. 69, No. 4
Department of Immunology, Strathclyde
Institute for Biomedical Sciences, University of
Strathclyde,1 and Victoria
Infirmary,3 Glasgow, Scotland, and
Nuffield Department of Pathology, University of Oxford,
John Radcliffe Hospital, Oxford, England,2
United Kingdom
Received 31 July 2000/Returned for modification 30 August
2000/Accepted 14 November 2000
A murine model was used to characterize the local immune and
inflammatory response during ocular toxoplasmosis. Major
histocompatibility complex (MHC) class I, normally expressed at low
levels in immune-privileged sites such as the eye, was up-regulated
during infection as determined by competitive reverse transcriptase
(RT)-PCR and immunocytochemistry for both Ocular toxoplasmosis (OT) is
associated with inflammation of the retina and uveal tract. It is a
recurring and progressive disease that can result in destruction of the
retina and loss of sight (6). The relative contribution of
the host inflammatory response versus parasite proliferation in causing
destruction of the retina has not been defined (29). The
eye is an immune-privileged site and inflammatory products such as
tumor necrosis factor The present study was undertaken to characterize further the immune
response during OT. To achieve this we employed a combination of
competitive reverse transcription-PCR (cRT-PCR) and immunocytochemistry (ICC). Although it cannot be assumed that the mRNA levels measured through cRT-PCR correlate absolutely with protein production, many
studies have found cRT-PCR to be a useful method for evaluating ongoing
immune responses. Infection was found to significantly alter the
expression of immune system components associated with immune privilege
in the eye; i.e., there was increased expression of Mice and T. gondii infections.
Female mice of
the 129/SVJ strain (WT) and IL-6 Tissue processing and histopathology.
Eyes were fixed in 0.1 M phosphate buffer (pH 7.4) containing 4% formaldehyde. Sections were
cut from paraffin-embedded tissues and stained with hematoxylin and
eosin stain. All sections were examined and assessed without knowledge
of the group from which they originated. The number of inflammatory
cells in the vitreous humor, retina, and choroid were graded from 1 to
3 as follows: 1, mild (less than 10 inflammatory cells per field at
×400 magnification); 2, moderate (between 11 and 20 inflammatory cells
per field at ×400 magnification); and 3, severe (between 21 and 30 inflammatory cells per field at ×400 magnification). The score at each
site was compared using the Mann-Whitney U test. In addition, the cysts in three consecutive sections were counted.
Immunocytochemistry.
Sections of the eyes processed for
histology were dewaxed, and the endogenous peroxidase was blocked prior
to pressure cooking for 90 s. Serial sections were then blocked
with 1% bovine serum albumin in Tris buffer and incubated with either
goat anti- RNA extraction.
Four weeks after infection, eyes from
infected or uninfected control SVJ or IL-6 Reverse transcription.
cDNA was produced from total RNA
using Moloney murine leukemia virus RT (Gibco BRL Life Technologies)
according to the manufacturer's specifications. In a 90-µl reaction
volume, 7 µg of RNA was combined with 18 µl of 5× first-strand
buffer (250 mM Tris-HCl [pH 8.3], 375 mM KCl, and 15 mM
MgCl2)-18 µl of deoxynucleoside triphosphate (dNTP) mix
(10 mM)-9 µl of 0.1 M dithiothreitol-80 U of RNasin ribonuclease
inhibitor (Promega)-500 ng of random hexamer primers (Promega)-1,200
U of Moloney murine leukemia virus RT. Following a 10-min preincubation
at 27°C, the mixture was incubated at 42°C for 60 min, and then the
reaction was terminated by heating at 95°C for 5 min. All cDNA was
stored at cRT-PCR for cytokine transcripts.
The level of cytokine
transcripts was assessed by cRT-PCR as described previously (5,
11, 30) using multispecific competitor plasmids pMUS
(32), pNIL (18), and pQRS (27).
cRT-PCR is a flexible system that easily assesses differences in
multiple immune mediators even in small amounts of nonlymphoid tissue
such as the eye. Although it cannot be assumed that mRNA levels
measured through cRT-PCR correlate absolutely with protein production, many studies have found this to be a useful method to evaluate ongoing
immune responses (5, 11, 18, 27, 30, 32). To ensure that
equal quantities of cDNA were used in PCR for each sample, levels of
transcript were first normalized against hypoxanthine-guanosine phosphoribosyl transferase (HPRT). To achieve this, PCR was first performed for HPRT in the absence of competitor (pQRS), and samples were adjusted until similar band intensities were observed. To confirm
normalization, PCR for HPRT was then performed in the presence of a
constant amount of competitor. Where necessary, samples were adjusted
until the resulting amplification resulted in equal intensities of
specific and competitor products for all of the samples
(30). All PCR mixtures were made to 25 µl and contained
a final concentration of 1× PCR buffer (50 mM KCl, 10 mM Tris-HCl [pH
9.0], and 0.1% Triton X-100)-1.5 mM MgCl2-200 µM for
each dNTP-0.5 µM for each primer-0.25 U of Taq DNA
polymerase (Promega). Cycling conditions included an initial
denaturation at 94°C for 3 min followed by 35 cycles of 94°C for
30 s, 58°C for 30 s, and 72°C for 1 min. Reactions were
finished with a final extension period for 10 min at 72°C. Primers
utilized in these experiments are as follows: HPRT forward and reverse
primers (5'-GGATTTGAAATTCCAGAG-3' and
5'-GAGGGTAGGCTGGCCTATGGCT-3', respectively) for use with
pQRS; Detection of parasites by RT-PCR.
To increase sensitivity
for the detection of parasite-specific transcripts in the eyes of
infected mice, a modified PCR followed by enhanced chemiluminescence
(ECL) was performed. RT-PCR was performed as outlined above using
biotin-labeled primers specific to the bradyzoite stage (LDH2) or the
tachyzoite stage (SAG2). Primers utilized were LDH2for
(5'-ATGACGGGTACCGTTAGC-3'), LDH2rev (5'-GCTCGCTTCATGAAAGCA-3'), SAG2for
(5'-TGATGCATGCTCCAGTGGTTC-3'), and SAG2rev
(5'-ACAAGCATGCGAGACCGG-3'). Following electrophoresis, the
PCR products were transferred onto a Hybond-N+ nylon
membrane (Amersham Pharmacia Biotech) by capillary transfer, as
described by Sambrook et al. (31). Following heat
fixation, the membrane was blocked overnight and incubated at room
temperature in a 1:32,000 dilution of streptavidin-horseradish
peroxidase (Amersham Pharmacia Biotech) for 1 h. After washing,
the membrane was flooded with ECL detection reagent (Amersham Pharmacia
Biotech) and exposed to film.
Cytokine expression in the eyes of infected WT mice.
Preliminary investigation of mRNA expression for selected cytokines in
the eyes of WT mice infected with T. gondii was carried out.
Samples were normalized against HPRT in the presence of pQRS as
described in Materials and Methods. Similar intensities of the lower
bands (specific product) and the corresponding upper bands (competitor
product) indicated that all samples were normalized relative to the
competitor and each other. For all subsequent PCRs, sample volumes
remained unchanged.
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.4.2589-2595.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Immunological Studies of Chronic Ocular
Toxoplasmosis: Up-Regulation of Major Histocompatibility Complex
Class I and Transforming Growth Factor
and a Protective Role
for Interleukin-6
![]()
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
2-microglobulin and the
MHC class I heavy chain. However, the eyes of chronically infected mice
also had increased levels of mRNA transcripts for transforming growth
factor
, a cytokine associated with immune privilege and
constitutively expressed in normal eyes. Transcripts for a number of
inflammatory mediators, including interleukin-6 (IL-6), were increased
during chronic infection. The role of IL-6 was further investigated by
comparing disease progression and the development of the local immune
response in wild-type (WT) and IL-6-deficient mice
(IL-6
/
mice). Following infection,
IL-6
/
mice developed more severe inflammation in the
retina and vitreous humor compared with WT mice. This increased
severity of disease was associated with reduced ocular IL-1
and
increased tumor necrosis factor
mRNA production compared with WT
mice. Moreover, the increased severity of disease in
IL-6
/
mice correlated with increased eye parasite
burden as determined by RT-PCR for the Toxoplasma gondii
bradyzoite-specific LDH2 gene. These results demonstrate
alterations to components of immune privilege as a result of ocular
toxoplasmosis and a role for IL-6 in controlling parasite numbers and
inflammation in the eye.
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
(TNF-
), gamma interferon (IFN-
), and
nitric oxide production have been linked to experimental autoimmune
uveitis (25, 39). Under normal circumstances, the eye
constitutively expresses transforming growth factor
(TGF-
) and
has low levels of major histocompatibility complex (MHC) class I
expression in order to down-regulate inflammatory mediators and the
immune response (33). In addition, high constitutive expression of Fas ligand on ocular cells would serve to induce apoptosis and down-regulate the function of T cells and NK cells (33, 34). Together these factors would generally serve to prevent damage or destruction of the eye as a result of inflammation. However, these anti-inflammatory processes may also contribute to an
immunological environment that is conducive to the survival and
multiplication of Toxoplasma gondii. For example, not only can TGF-
down-regulate the ability of NK cells to respond to T. gondii products (15), but also TGF-
can
antagonize the activation of macrophages by reducing their ability to
produce nitric oxide, which is an important anti-T. gondii
effector mechanism in murine and human cells (13). In
addition, TGF-
can prevent the induction of the tryptophan-degrading
enzyme indolamine, which has been shown to prevent parasite
multiplication in human cells (21). Furthermore, the
relatively low expression of MHC class I molecules in the eye
(34) would serve to reduce the potential activities of
anti-T. gondii cytolytic CD8+ T cells, which are
known to play a significant role in killing T. gondii-infected cells (7, 10, 24). Immunological
control of T. gondii in the eye is therefore complex,
because many of the mechanisms required to control parasite numbers may
also adversely influence immune privilege and cause tissue damage.
2-microglobulin
and TGF-
. As previously described, infection was found to induce or
increase levels of mRNA transcripts for a number of inflammatory
mediators, including TNF-
and inducible nitric oxide synthase
(iNOS), in ocular tissue. Both of these mediators are known to have a
protective role for the host during OT (9, 14, 30).
Previous studies have found that infection of human retinal pigment
epithelial (HRPE) cells with T. gondii induces interleukin-6
(IL-6) (22). Accordingly, we also found transcripts for
IL-6 in the eyes of mice infected with T. gondii. The role
of IL-6 was therefore investigated by comparing disease progression and
the development of the local immune response in wild-type (WT) and
IL-6-deficient (IL-6
/
) mice. Following infection with
T. gondii, IL-6
/
mice developed more severe
inflammation in their retinas, vitreous humor, and uveas than did WT
mice. The increased severity of disease in IL-6
/
mice
compared with WT mice was associated with increased numbers of parasites.
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
/
mice of the same
genetic background, as previously described (17), were bred and maintained at the University of Strathclyde. Mice were infected with 10 T. gondii tissue cysts (Beverley strain) by
the intraperitoneal route at 4 to 6 weeks of age, as previously
described (28). Four weeks after infection, eyes were
removed from both infected and age-matched uninfected control animals
for histopathological examination, ICC, or RNA extraction. This time
point was chosen because preliminary studies found that OT was not
clearly evident at 3 weeks postinfection, and it was also chosen to
precede the mortality evident after 4 weeks postinfection.
2-microglobulin (Santa Cruz Biotechnology, Inc.), mouse
anti-BAG1 (bradyzoite specific antibody [4a]) or fluorescein
isothiocyanate-conjugated mouse anti-mouse H-2Db clone no. KH95
(Pharmingen, Oxford, United Kingdom) in Tris buffer. After washing,
sections were stained with the appropriate second antibody conjugated
to peroxidase, and the reaction product was developed using
diaminobenzidine and hydrogen peroxide as a chromogen. Alternatively,
sections stained for H-2Db were examined by fluorescence microscopy.
Slides were counterstained with hematoxylin prior to examination. To identify any possible quantitative difference, sections of the eyes
from infected and uninfected controls of both WT and
IL-6
/
mice were stained in parallel using identical
reagents and incubation times.
/
mice were
carefully removed and homogenized in 1 ml of TRIzol reagent (Gibco BRL
Life Technologies, Paisley, United Kingdom). Total RNA was isolated
following a protocol based on the single-step acid guanidinium
thiocyanate-phenol-chloroform RNA isolation method (8).
20°C until used in PCR.
2-microglobulin forward and reverse primers
(5'-TGACCGGCTTGTATGCTATC-3' and
5'-CAGTGTGAGCCAGGATATAG-3') for pMUS; TGF-
forward and
reverse primers (5'-ACCGCAACAACGCCATCTAT-3' and
5'-GTAACGCCAGGAATTGTTGC-3') for pMUS; IL-1
forward
and reverse primers (5'-CAGTTCTGCCATTGACCATC-3' and
5'-TCTCACTGAAACTCAGCCGT-3') for pMUS; TNF-
forward and
reverse primers (5'-TCTCATCAGTTCTATGGCCC-3' and
5'-GGGAGTAGACAAGGTACAAC-3') for pMUS; IL-6 forward and
reverse primers (5'-GTTCTCTGGGAAATCGTGGA-3' and
5'-TGTACTCCAGGTAGCTATGG-3') for pMUS; and iNOS forward and reverse primers (5'-AGCTCCTCCCAG GACCACAC-3' and
5'-ACGCTGAGTACCTCATTGGC-3') for use with pNIL. IFN-
forward and reverse primers (5'-GCTCTGAGACAATGAACGCT-3' and
5'-AAAGAGATAATCTGGCTCTGC-3') and IL-10 forward and reverse primers (5'-AGCCGGGAAGACAATAACTG-3' and
5'-CATTTCCGATAAGGCTTGG-3') were also used in the absence of
competitor. The amounts of specific and competitor product of each
reaction were assessed from scanned images of ethidium bromide-stained
gels using NIH Image. The ratios of the total volume (density times
area) of competitor to specific products were determined, and
statistical analyses were performed using the Mann-Whitney U test.
![]()
RESULTS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
2-microglobulin and TGF-
. Transcripts for both of these molecules were present in the eyes of
normal control mice. Following infection, an increase in the level of
transcript for
2-microglobulin in the eyes of infected mice was
demonstrated by an increase in the intensity of specific product
relative to the pMUS competitor construct. TGF-
transcript was also
increased in the eyes of T. gondii-infected mice. IL-6 transcript was absent from the eyes of normal control mice, but it was
present in the eyes of all infected mice. These results are not shown,
because these results are also evident in subsequent experiments that
compare WT and IL-6
/
mice (Fig.
1a).

View larger version (58K):
[in a new window]
FIG. 1.
The effect of T. gondii infection on
intraocular expression of
2-microglobulin, TGF-
, IL-1
,
TNF-
, IL-6, and iNOS, as measured by cRT-PCR. (a) Samples were first
normalized for HPRT expression (note similar intensities of upper band
[competitor product] with lower band [specific product]). The
quantity of sample used to achieve this normalization was used in
subsequent PCR.
2-Microglobulin expression was increased in infected
mice compared with uninfected control mice (note increased intensities
of lower band [specific product] compared with upper band
[competitor product] in infected mice, but equal intensity of both
bands in control samples). TGF-
was present in control samples but
was up-regulated during infection (note low levels or absence of lower
band [specific product] in control samples due to competition with
competitor [upper band]). However, in samples from infected mice,
both competitor and specific products are present, indicating increased
expression. IL-1
transcripts were absent or present at low levels in
control samples (lower band). Expression of IL-1
was increased in WT
mice following infection (note presence of lower band in all samples)
but not to the same extent as in IL-6
/
mice (note
increased intensity of upper band [competitor product] in
IL-6
/
samples compared with lower band [specific
product]). TNF-
expression was increased in IL-6
/
samples following infection but not in WT mice (note presence of lower
band [specific product] in all samples compared with low intensity or
absence in WT samples). IL-6 expression (albeit nonfunctional) was
increased in IL-6
/
samples following infection but not
in WT mice (note presence of lower band [specific product] in all
samples compared with low intensity or absence in WT samples).
Expression of iNOS was low or absent in control mice but increased
during infection (note increased intensity of upper bands [specific
product] relative to lower bands [competitor product] in infected
mice compared with control mice). IFN-
and IL-10 transcripts were
present in the eyes of both control and infected mice of each strain
but at low levels which precluded comparison using a competitive
construct (results not shown). These results are representative of two
replicate experiments. (b) Transcripts for T. gondii LDH2
were absent from control mice but were present at low levels in four of
five WT mice and at high levels in four of five IL-6
/
mice (note artifact in lane 2 for WT mice). These results are
representative of two replicate experiments.
Comparison of ocular pathology in infected WT and
IL-6
/
mice.
The relevance of our preliminary
finding that IL-6 transcripts are present in the eyes of mice infected
with T. gondii was tested by comparing the severity of OT in
WT and IL-6
/
mice. The eyes of both WT and
IL-6
/
mice infected with T. gondii had
inflammation in their retinas, vitreous humor, and choroid (Table
1). Inflammatory cells were also present
within the ciliary body and anterior chamber. Retinal inflammation was
most marked in the inner retinal layers. When the inflammation in each
site was compared using the Mann-Whitney U test, the score for
inflammation in the retina and vitreous humor in IL-6
/
mice was significantly greater than in WT mice (retina, P = 0.027; vitreous humor, P = 0.026). Similar results
were obtained in four experiments using male or female mice. Female
mice generally had more severe inflammation than male mice (results not
shown). In some of the eyes from IL-6
/
mice, there were
clusters of several cysts. Although there were no significant
differences in the overall cyst burdens, IL-6
/
mice
generally had increased numbers of cysts in their eyes compared with WT
mice, and cysts were often found in clusters rather than as individual
cysts as in the WT mice. T. gondii tissue cysts stained
positive for BAG1 but, as expected, were negative for
2-microglobulin (Fig. 2A and B). Eyes
from uninfected control mice were normal.
|
|
Comparison of cytokine expression and parasite numbers in the eyes
of infected WT and IL-6
/
mice.
The ocular immune
response was compared in WT and IL-6
/
mice infected
with T. gondii to determine whether the increased severity in IL-6
/
mice was due to an increased inflammatory
response or to greater parasite burdens. Samples from eyes of three
uninfected and five infected mice each for the WT and
IL-6
/
strains were again normalized by performing
competitive RT-PCR for HPRT (Fig. 1a).
2-microglobulin (P = 0.0245), TGF-
(P = 0.0245), iNOS (P = 0.0245), and IL-6
(P = 0.0245) were observed in infected WT and IL-6
/
mice (Fig. 1a) (IL-6 transcripts in
IL-6
/
mice are nonfunctional). IL-1
transcript was
also increased during T. gondii infection (P = 0.0245). However, this increase was greater in WT than in
IL-6
/
mice (P = 0.0163). Conversely,
although transcripts for TNF-
were expressed in uninfected control
eyes, TNF-
was induced to a greater extent in IL-6
/
mice than in WT mice (P = 0.0163) (Fig. 1a). IFN-
and IL-10 transcripts were present in the eyes of both control and
infected mice of each strain but at low levels which precluded
comparison using a competitive construct (results not shown).
Finally, we investigated the amount of transcript of
bradyzoite-specific LDH2 gene and tachyzoite-specific
SAG2 gene as a semiquantitative analysis of the number of
parasites in the eyes of infected mice. Sensitivity of the PCR was
increased at least 10-fold by using biotin-labeled primers and
subsequent transfer to a nylon membrane and ECL. Despite this,
SAG2 transcript could only be detected in a sample from one
mouse, indicating that very few tachyzoites were present in the eyes of
infected mice (data not shown). LDH2 transcript was observed
in the eyes of both WT and IL-6
/
mice, indicating the
presence of the bradyzoite cyst stages. Levels of LDH2
transcripts were generally higher in the eyes of infected
IL-6
/
mice compared to WT mice (Fig. 1b) in two
experiments (P = 0.374).
Comparison of staining for
2-microglobulin and MHC class I heavy
chain in the eyes of uninfected and infected WT and
IL-6
/
mice.
In the eyes from infected WT and
IL-6
/
mice, there was membranous staining for
2-microglobulin in the ciliary body epithelium (Fig. 2D), ganglion
cell layer of the retina (Fig. 2F), and inflammatory cells within the
retina (Fig. 2G). Cytoplasmic staining was also identified in the
ciliary body epithelium and in the retinal pigment epithelium (Fig. 2D
and F). Similar staining was observed for MHC class I (results not
shown). There was no difference in the pattern or intensity of staining
between WT and IL-6
/
mice (data not shown). Eyes from
uninfected control mice were negative for
2-microglobulin (Fig. 2E)
and MHC class I (results not shown).
| |
DISCUSSION |
|---|
|
|
|---|
The pathogenesis of murine OT was investigated. Of particular
interest was the extent to which factors associated with the immune
privilege nature of the eye were compromised. A hallmark of immune
privilege in the eye is constitutive expression of TGF-
(33). We also found constitutive expression of TGF-
in
the eye, but in addition we found that OT significantly increases levels of TGF-
transcripts. While this increase in levels of TGF-
may serve to maintain immune privilege and to reduce damage due to
inflammation, it may also have beneficial effects on the multiplication
and survival of T. gondii. For example, TGF-
has been
shown not only to reduce the ability of NK cells, a major source of
IFN-
, to respond to T. gondii but also to markedly down-regulate macrophage functions, including their ability to produce
nitric oxide and indolamine (13, 15, 21). IFN-
is the
major mediator of resistance against T. gondii, and
treatment of a number of nonphagocytic human cells has been shown to
prevent the multiplication of T. gondii by inducing
indolamine, which degrades tryptophan and starves the parasite of this
amino acid (26, 36). Following stimulation with IFN-
,
nitric oxide has been shown to mediate killing of T. gondii
in a number of murine and human cell types, and, significantly, nitric
oxide has been shown to play a protective role during murine OT
(19).
Low levels of MHC class I expression are another hallmark of immune
privilege in the eye (34). This study found that MHC class
I is up-regulated in the eyes of mice with OT, as demonstrated by
increased levels of
2-microglobulin mRNA transcripts and
up-regulation of cell surface MHC class I. Expression of MHC class I
has been shown to be increased by IFN-
, and accordingly we did find
transcripts for IFN-
in the eyes of infected but not uninfected mice
(3). Up-regulation of MHC class I in the cells of the eye
during infection would generally facilitate CD8+ cytotoxic
T lymphocyte (CTL) killing of T. gondii-infected cells and
may serve to limit parasite multiplication. Notably, CD8+
CTLs have been demonstrated in vitro to lyse T. gondii-infected cells (12, 35). In addition, adoptive
transfer of CD8+ T cells from chronically infected mice to
naïve mice has also been shown to mediate protection against
infection with T. gondii (24). The accentuation
of one aspect of immune privilege, namely TGF-
production, coupled
with the increased expression of MHC class I, which represents an
ablation of immune privilege during OT, requires explanation. We
suggest that the up-regulation of MHC class I may confer ability in the
immune system to efficiently and specifically recognize and lyse
infected cells, while the up-regulation of TGF-
may protect
uninfected cells from nonspecific inflammatory responses.
During the course of these studies a number of inflammatory mediators
were up-regulated in the eyes of mice during infection, including
TNF-
, iNOS, IL-1, and IL-6. While TNF-
and iNOS have previously
been shown to be increased and to play a beneficial role during OT, the
roles of IL-1 and IL-6 have not been investigated (9, 14,
30). IL-6 has, however, been previously detected in the eyes of
cats with OT and in the vitreous humor of infected human eyes
(20, 22). Furthermore, a recent study found that in vitro
infection of HRPE cells with T. gondii induced the
transcription of a number of inflammatory mediators, including IL-6
(23). We therefore investigated the role of IL-6 during OT
by comparing disease progression and the local immune response in WT
and IL-6
/
mice.
Following infection with T. gondii, IL-6
/
mice developed a more severe inflammation in their retina vitreous than
WT mice. Previous studies have provided conflicting data concerning the role of IL-6 during toxoplasmosis. Thus, while in vitro studies have
found that IL-6 inhibits IFN-
-mediated T. gondii killing (4), further studies suggest that IL-6 may reduce parasite multiplication by promoting encystment (40). Murine models
of disease again provide conflicting data regarding the role of IL-6 (16). In support of a disease-promoting role,
neutralization of IL-6 has been shown to reduce cyst burdens and the
severity of the inflammatory process in the brains of infected animals (37). In contrast, a host-protective role is supported by
the increased mortality and severity of neurological disease observed in IL-6
/
mice compared with WT mice after infection
with T. gondii (16). Nevertheless, IL-6 has
been shown to have a role in down-regulating the inflammatory response
by inhibiting the production of IL-1 and TNF-
(1, 2,
38). This would suggest that IL-6 could promote parasite growth
while reducing pathology. Further studies were therefore performed to
determine whether the increased severity of ocular inflammation
observed in IL-6
/
mice was due to increased parasite
multiplication and associated destruction of host cells or was a direct
consequence of a failure to control inflammation in the absence of
IL-6. In agreement with our preliminary studies, cRT-PCR revealed that
2-microglobulin and TGF-
were increased in infected WT and
IL-6
/
mice compared with uninfected controls. The
inflammatory mediators IL-1
, TNF-
, and iNOS were also
up-regulated in the eyes of both WT and IL-6
/
mice
following infection, as were those of IL-6. Furthermore, IL-6
/
mice had increased levels of IL-6 transcripts,
albeit nonfunctional, compared with WT mice. This is consistent with
previous studies of these mice and suggests a role for IL-6 in
regulation of its transcription (17).
Whereas there was no significant difference in the levels of iNOS
transcript between mouse strains, IL-6
/
mice had
reduced ocular IL-1
. This finding indicates that the increased
susceptibility of the IL-6
/
mice over WT mice is not
due to reduced nitric oxide production. Consistent with previous
studies, which found that mice deficient in IL-6 produced more TNF-
in response to lipopolysaccharide challenge than did WT mice
(17) following infection with T. gondii, the
eyes of IL-6
/
mice had increased levels of transcript
for TNF-
compared with WT mice. While previous studies demonstrated
a protective role for TNF-
during OT (9), the
IL-6
/
mice had more severe ocular inflammation despite
producing more TNF-
than WT mice. Furthermore, in a series of
experiments, IL-6
/
mice generally had increased
parasite burdens in their eyes compared with WT mice, as determined by
RT-PCR for the T. gondii bradyzoite-specific LDH2
gene. The inability of histological examination to detect this
difference is undoubtedly due to the relative rarity of tissue cysts in
the eye and the fact that this type of analysis examines only a few
cross sections of the eye. In comparison, the RT-PCR method assesses
parasite number in the entire eye and in this respect provides a clear
advantage over histological examination alone. It is interesting that
transcripts for SAG2 were generally not detectable in the
eyes of either WT or IL-6
/
mice by RT-PCR, indicating
that the form of the parasite present was predominately the bradyzoite
and not the tachyzoite. It is unlikely that this is a limitation of the
method used, because we can detect as few as 10 tachyzoites in a sample.
Whether the protective role of IL-6 during OT is due to ocular or
systemic immunity remains to be determined. However, a role for IL-6 in
the ocular site is suggested, as transcripts for IL-6 are found only in
the eyes of infected mice. Furthermore, in IL-6
/
mice,
IL-1
production is increased while TNF-
production is decreased
compared with that in WT animals. Significantly, therefore, these
studies do demonstrate that intraocularly produced IL-6 does not have a
proinflammatory or disease-potentiating effect during OT.
Together these results demonstrate that OT selectively induces changes
to immune privilege in the eye that may favor MHC class I-mediated
killing of infected cells while limiting inflammation by increasing
TGF-
production. In addition, IL-6 plays a beneficial role in
limiting parasite burden and inflammation in the eyes of mice infected
with T. gondii.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Department of Immunology, Strathclyde Institute for Biomedical Sciences, University of Strathclyde, 27 Taylor St., Glascow G4 ONR, Scotland, United Kingdom. Phone: 0141 548 4823, ext. 3748. Fax: 0141 548 4823. E-mail: c.w.roberts{at}strath.ac.uk.
Editor: J. M. Mansfield
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Aderka, D., J. Le, and J. Vilvek. 1989. IL-6 inhibits lipopolysaccharide-induced tumor necrosis factor production in cultured human monocytes, U937 cells, and in mice. J. Immunol. 143:3517-3523[Abstract]. |
| 2. | Akira, S., T. Hirano, T. Taga, and T. Kishimoto. 1990. Biology of multifunctional cytokines: IL-6 and related molecules (IL-1 and TNF). FASEB J. 4:2860-2867[Abstract]. |
| 3. |
Barez, S.,
D. T. Boumpas,
C. M. Percopo,
E. D. Anastassiou,
J. J. Hooks, and B. Detrick.
1993.
Modulation of major histocompatibility complex class 1 genes in human retinoblastoma cells by interferons.
Investig. Ophthalmol. Vis. Sci.
34:2613-2621 |
| 4. | Beaman, M. H., C. A. Hunter, and J. S. Remington. 1994. Enhancement of intracellular replication of Toxoplasma gondii by IL-6: interactions with IFN-gamma and TNF-alpha. J. Immunol. 153:4583-4587[Abstract]. |
| 4a. | Bohne, W., V. Gross, D. J. Ferguson, and J. Heesemann. 1995. Cloning and characterization of a bradyzoite-specifically expressed gene (hsp30/bag1) of Toxoplasma gondii, related to genes encoding small heat-shock proteins of plants. Mol. Microbiol. 16:1221-1230[CrossRef][Medline]. |
| 5. |
Bouaboula, M.,
P. Legoux,
B. Pessegue,
B. Delpech,
X. Dumont,
M. Piechaczyk,
P. Casellas, and D. Shire.
1992.
Standardization of mRNA titration using a polymerase chain reaction method involving co-amplification with a multispecific internal control.
J. Biol. Chem.
267:21830-21838 |
| 6. | Boyer, K. M. 1996. Diagnosis and treatment of congenital toxoplasmosis. Adv. Pediatr. Infect. Dis. 11:449-467[Medline]. |
| 7. | Brown, C. R., and R. McLeod. 1990. Class I MHC genes and CD8+ T cells determine cyst number in Toxoplasma gondii infection. J. Immunol. 145:3438-3441[Abstract]. |
| 8. | Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159[Medline]. |
| 9. | Gazzinelli, R. T., A. Brezin, Q. Li, R. B. Nussenblatt, and C. C. Chan. 1994. Toxoplasma gondii: acquired ocular toxoplasmosis in the murine model, protective role of TNF-alpha and IFN-gamma. Exp. Parasitol. 78:217-229[CrossRef][Medline]. |
| 10. | Gazzinelli, R. T., F. T. Hakim, S. Hieny, G. M. Shearer, and A. Sher. 1991. Synergistic role of CD4+ and CD8+ T lymphocytes in IFN-gamma production and protective immunity induced by an attenuated Toxoplasma gondii vaccine. J. Immunol. 146:286-292[Abstract]. |
| 11. |
Gilliland, G.,
S. Perrin,
K. Blanchard, and H. F. Bunn.
1990.
Analysis of cytokine mRNA and DNA: detection and quantitation by competitive polymerase chain reaction.
Proc. Natl. Acad. Sci. USA
87:2725-2729 |
| 12. | Hakim, F. T., R. T. Gazzinelli, E. Denkers, S. Hieny, G. M. Shearer, and A. Sher. 1991. CD8+ T cells from mice vaccinated against Toxoplasma gondii are cytotoxic for parasite-infected or antigen-pulsed host cells. J. Immunol. 147:2310-2316[Abstract]. |
| 13. |
Hausmann, E. H.,
S. Y. Hao,
J. L. Pace, and M. J. Parmely.
1994.
Transforming growth factor 1 and gamma interferon provide opposing signals to lipopolysaccharide-activated mouse macrophages.
Infect. Immun.
62:3625-3632 |
| 14. |
Hayashi, S.,
C. C. Chan,
R. T. Gazzinelli,
N. T. Pham,
M. K. Cheung, and F. G. Roberge.
1996.
Protective role of nitric oxide in ocular toxoplasmosis.
Br. J. Ophthalmol.
80:644-648 |
| 15. | Hunter, C. A., L. Bermudez, H. Beernink, W. Waegell, and J. S. Remington. 1995. Transforming growth factor-beta inhibits interleukin-12-induced production of interferon-gamma by natural killer cells: a role for transforming growth factor-beta in the regulation of T cell-independent resistance to Toxoplasma gondii. Eur. J. Immunol. 25:994-1000[Medline]. |
| 16. | Jebbari, H., C. W. Roberts, D. J. P. Ferguson, H. Bluethmann, and J. Alexander. 1998. A protective role for IL-6 during early infection with Toxoplasma gondii. Parasite Immunol. 20:231-239[CrossRef][Medline]. |
| 17. | Kopf, M., H. Baumann, G. Freer, M. Freudenberg, M. Lamers, T. Kishimoto, R. Zinkernagel, H. Bluethmann, and G. Kohler. 1994. Impaired immune and acute-phase responses in interleukin-6-deficient mice. Nature 368:339-342[CrossRef][Medline]. |
| 18. |
Kopf, M.,
F. Brombacher,
G. Kohler,
G. Kienzle,
K. H. Widmann,
K. Lefrang,
C. Humborg,
B. Ledermann, and W. Solbach.
1996.
IL-4-deficient Balb/c mice resist infection with Leishmania major.
J. Exp. Med.
184:1127-1136 |
| 19. | Langermans, J. A. M., D. H. M. E. B. Van, P. H. Nibbering, P. S. Hiemstra, L. Fransen, and F. R. Van. 1992. IFN-gamma-induced L-arginine-dependent toxoplasmastatic activity in murine peritoneal macrophages is mediated by endogenous tumor necrosis factor-alpha. J. Immunol. 148:568-574[Abstract]. |
| 20. | Lappin, M. R., S. W. Dow, J. S. Reif, and M. J. Chavkin. 1997. Elevated interleukin 6 activity in aqueous humor of cats with uveitis. Vet. Immunol. Immunopathol. 58:17-26[CrossRef][Medline]. |
| 21. | MacKenzie, C. R., R. G. Gonzalez, E. Kniep, S. Roch, and W. Daubener. 1999. Cytokine mediated regulation of interferon-gamma-induced IDO activation. Adv. Exp. Med. Biol. 467:533-539[Medline]. |
| 22. |
Murray, P. I.,
R. Hoekzema,
H. M. A. C. Van,
H. F. D. De, and A. Kijlstra.
1990.
Aqueous humor interleukin-6 levels in uveitis.
Investig. Ophthalmol. Vis. Sci.
31:917-920 |
| 23. |
Nagineni, C. N.,
B. Detrick, and J. J. Hooks.
2000.
Toxoplasma gondii infection induces gene expression and secretion of interleukin 1 (IL-1), IL-6, granulocyte-macrophage colony-stimulating factor, and intercellular adhesion molecule 1 by human retinal pigment epithelial cells.
Infect. Immun.
68:407-410 |
| 24. | Parker, S. J., C. W. Roberts, and J. Alexander. 1991. CD8+ T cells are the major lymphocyte subpopulation involved in the protective immune response to Toxoplasma gondii in mice. Clin. Exp. Immunol. 84:207-212[Medline]. |
| 25. |
Parks, D. J.,
M. K. Cheung,
C. C. Chan, and F. G. Roberge.
1994.
The role of nitric oxide in uveitis.
Arch. Ophthalmol.
112:544-546 |
| 26. |
Pfefferkorn, E. R.
1984.
Interferon gamma blocks the growth of Toxoplasma gondii in human fibroblasts by inducing the host cells to degrade tryptophan.
Proc. Natl. Acad. Sci. USA
81:908-912 |
| 27. | Reiner, S. L., S. Zheng, D. B. Corry, and R. M. Locksley. 1993. Constructing polycompetitor cDNAs for quantitative PCR. J. Immunol. Methods 165:37-46[CrossRef][Medline]. |
| 28. | Roberts, C. W., S. M. Cruickshank, and J. Alexander. 1995. Sex-determined resistance to Toxoplasma gondii is associated with temporal differences in cytokine production. Infect. Immun. 63:2549-2555[Abstract]. |
| 29. | Roberts, F., and R. McLeod. 1999. Pathogenesis of toxoplasmic retinochoroiditis. Parasitol. Today 15:51-57[CrossRef][Medline]. |
| 30. | Roberts, F., C. W. Roberts, D. J. Ferguson, and R. McLeod. 2000. Inhibition of nitric oxide production exacerbates chronic ocular toxoplasmosis. Parasite Immunol. 22:1-5[CrossRef][Medline]. |
| 31. | Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y. |
| 32. | Shire, D. 1993. Open exchange of reagents and information useful for the measurement of cytokine mRNA levels by PCR. Eur. Cytokine Netw. 4:161. |
| 33. | Streilein, J. W., B. R. Ksander, and A. W. Taylor. 1997. Immune deviation in relation to ocular immune privilege. J. Immunol. 158:3557-3560[Abstract]. |
| 34. | Streilein, J. W., and J. Stein-Streilein. 2000. Does innate immune privilege exist? J. Leukoc. Biol. 67:479-487[Abstract]. |
| 35. | Subauste, C. S., A. H. Koniaris, and J. S. Remington. 1991. Murine CD8+ cytotoxic T lymphocytes lyse Toxoplasma gondii-infected cells. J. Immunol. 147:3955-3959[Abstract]. |
| 36. |
Suzuki, Y.,
M. A. Orellana,
R. D. Schreiber, and J. S. Remington.
1988.
Interferon-gamma: the major mediator of resistance against Toxoplasma gondii.
Science
240:516-518 |
| 37. |
Suzuki, Y.,
Q. Yang,
F. K. Conley,
J. S. Abrams, and J. S. Remington.
1994.
Antibody against interleukin-6 reduces inflammation and numbers of cysts in brains of mice with toxoplasmic encephalitis.
Infect. Immun.
62:2773-2778 |
| 38. | Ulich, T. R., S. Yin, K. Guo, E. S. Yi, D. Remick, and J. Del Castillo. 1991. Intratracheal injection of endotoxin and cytokines. II. Interleukin 6 and transforming growth factor beta inhibits acute inflammation. Am. J. Pathol. 138:1097-1101[Abstract]. |
| 39. | Wang, Z. Y., and R. Hakanson. 1995. Role of nitric oxide (NO) in ocular inflammation. Br. J. Pharmacol. 116:2447-2450[Medline]. |
| 40. | Weiss, L. M., D. Laplace, P. M. Takvorian, H. P. Tanowitz, A. Cali, and M. Wittner. 1995. A cell culture system for the study of the development of bradyzoites. J. Eukaryot. Microbiol. 42:150-157[Medline]. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»